Ipca Laboratories plans Indonesian acquisition

29 Sep 2011 Evaluate
Ipca Laboratories Ltd plans to acquire a pharmaceutical company in Indonesia with a view to enter the largest South-East Asian market.The company has put together a $ 20 million war chest for the acquisition, to be made within the next few months, and a number of companies have been short listed. The company needs good access to the Indonesian market and an established pharmaceutical company would be good vehicle to market Indian pharma products in Indonesia.

Ipca Laboratories Share Price

1585.60 1.35 (0.09%)
23-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1814.50
Dr. Reddys Lab 1340.80
Cipla 1476.45
Lupin 2160.20
Zydus Lifesciences 972.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.